Searched for
SANOFI MUMBAI
Sanofi India decides to put headquarters in Mumbai on the blockSanofi's Indian subsidiary is planning to sell its 150,000 sq ft standalone property in Mumbai's Powai area, which serves as its current he...- GSK, Sanofi team up to bring out Covid-19 vaccineTwo of the world's largest vaccine manufacturers, Sanofi and GlaxoSmithKline, are coming together to work on a Covid-19 vaccine, which if i...
- Sanofi, Boehringer Ingelheim close business swap in IndiaSanofi is excited to embrace the incoming CHC brands and people associated with this business, as this is in line with objective of boostin...
- Sanofi sells its Andheri building in Mumbai for Rs 111 croreDrug firm Sanofi India has sold its commercial property, land along with a building known as 'Aventis House' in Mumbai, for Rs 111 crore.
- World's 1st dengue vaccine likely by 2015: SanofiCountry Head, Sanofi Pasteur, Stephan Barth, said dengue is a serious health concern in India, causing a significant but under-reported bur...
- Glenmark receives $5 million milestone payment from SanofiGlenmark Pharma got $5 mn as a milestone payment from Sanofi for a new drug to treat chronic auto-immune disorders, taking total payments r...
- Sanofi India acquires office space in PowaiFrench multinational pharmaceutical company Sanofi's Indian subsidiary has acquired 150,000 sq ft of office space at its new project in Pow...
- Sanofi India launches new product in headache segmentHealthcare service provider Sanofi India, is aiming at a four per cent market share in the headache segment currently valued at Rs 233 crore
- Sanofi charts India-specific strategy to boost shareFrench drug maker Sanofi says it is considering an India-specific strategy to increase its share in the country’s Rs 65,000-crore drug mark...
- Aventis Pharma renamed as Sanofi IndiaThe shareholders of the company had earlier approved the name change at the annual general meeting held on May 3, a company statement said.
- US court rules against Sun Pharma over cancer drugFrench drugmaker Sanofi today said a US court has ruled in its favour in a patent litigation against Sun Pharmaceuticals over Eloxatin.
- Sanofi expects 50 pc Indian market share for flu vaccinesThe co today launched 'Mothers Against Flu', a facebook community of mothers. The company has roped in actress Raveena Tandon for the campa...
- Sanofi-Aventis in advanced talks to buy majority stake in Universal Medicare to scale up OTC biz in IndiaAccording to a person close to the deal, Sanofi-Aventis may buy a majority stake or key brands valuing the Indian company at around Rs 450 ...
- Merck plans to shift India head office to MumbaiUS-based drugmaker Merck plans to relocate headquarter of its India office to Mumbai, making it the third major pharma company to shift key...
- Sanofi-Aventis scans India for acquisitionsSanofi-Aventis which bought companies in Brazil, Mexico, and the home-grown Shanta Biotech this year, has sent a delegation to India to fin...
- Sanofi Aventis-Piramal deal falls through over valuationFrench pharmaceutical giant Sanofi Aventis’ proposed deal to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through...
- Sanofi Aventis's Piramal plans fall throughFrench pharma major Sanofi Aventis's plans to acquire a majority stake in Mumbai-based Piramal Healthcare has fallen through due to differe...
- Piramal Health up 13% on Sanofi stake buyThe news of French drug major Sanofi-Aventis picking up stake in Piramal Healthcare at a premium has resulted in its stock price trading at...
- Lupin loses patent suit in AmericaPharmaceutical company Lupin on Thursday said a district court in the US has ruled against the company in a patent infringement suit.
- Sanofi-Aventis revises open offer for Aventis PharmaThe schedule of Sanofi-Aventis' open offer for shareholders of Aventis Pharma Ltd has been revised by DSP Merrill Lynch, manager of the off...
Load More
